Literature DB >> 26777992

The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancy.

Allison A Gockley1, Alexander Melamed1, Naima T Joseph1, Mark Clapp1, Sue Yazaki Sun2, Donald P Goldstein3, Neil S Horowitz3, Ross S Berkowitz4.   

Abstract

OBJECTIVE: To compare the age-specific incidence of complete (CM) and partial molar (PM) pregnancy in a large tertiary care center in the United States.
METHODS: Incidence rates of CM and PM per 10,000 live births were calculated using databases from Brigham and Women's Hospital, between 2000 and 2013. Age-specific rates were calculated for women younger than 20 years old (adolescents), 20-39 years old (average age), and 40 years and older (advanced maternal age). Pearson χ(2) test was used to evaluate potential differences among groups. Rate ratios (RR) and 95% confidence intervals (CI) were used to compare risk of molar pregnancy among average age women with that of adolescents and women of advanced age. Holm-Bonferonni adjustment was used to correct for multiple comparisons.
RESULTS: Between 2000 and 2013, there were 255 molar pregnancies (140 CM and 115 PM) and 105,942 live births, corresponding to a molar pregnancy rate of 24 per 10,000 live births (95% CI 21-27). Rates of CM and PM were 13 (95% CI 11-16) and 11 (95% CI 9-14) per 10,000 live births respectively. The incidence of CM differed significantly among maternal age groups (p<0.001). Compared to average age women, adolescents were 7.0 times as likely to develop CM (95% CI 3.6-8.9, p<0.001), and women with advanced maternal age were nearly twice as likely (1.9, 95% CI 1.8-4.7, p=0.002). The rate of PM did not vary significantly among age groups (p=0.26).
CONCLUSIONS: Adolescence and advanced maternal age were associated with increased risk of complete mole, but not partial mole.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complete mole; Maternal age; Partial mole

Mesh:

Year:  2016        PMID: 26777992     DOI: 10.1016/j.ygyno.2016.01.005

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Clinical presentation and treatment outcome of molar pregnancy: Ten years experience at a Tertiary Care Hospital in Dammam, Saudi Arabia.

Authors:  Ayman A Al-Talib
Journal:  J Family Community Med       Date:  2016 Sep-Dec

2.  A pilot randomized controlled clinical trial of second uterine curettage versus usual care to determine the effect of re-curettage on patients' need for chemotherapy among women with low risk, nonmetastatic gestational trophoblastic neoplasm in Urmia, Iran.

Authors:  Haleh Ayatollahi; Zahra Yekta; Elnaz Afsari
Journal:  Int J Womens Health       Date:  2017-09-21

3.  Incidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study.

Authors:  Jin-Sung Yuk; Jong Chul Baek; Ji Eun Park; Hyen Chul Jo; Ji Kwon Park; In Ae Cho
Journal:  PeerJ       Date:  2019-02-20       Impact factor: 2.984

4.  Incidence and outcome of gestational trophoblastic disease in lower Egypt.

Authors:  Ahmed Zakaria; Reda Hemida; Waleed Elrefaie; Ehsan Refaie
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

5.  Decreasing incidence of registered hydatidiform moles in Denmark 1999-2014.

Authors:  Helle Lund; Mogens Vyberg; Helle Højmark Eriksen; Anni Grove; Annette Østergaard Jensen; Lone Sunde
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.